A tug-of-war between driver and passenger mutations in cancer and other adaptive processes
Abstract
Cancer
progression is an example of a rapid adaptive process where evolving
new traits is essential for survival and requires a high mutation rate.
Precancerous cells acquire a few key mutations that drive rapid
population growth and carcinogenesis. Cancer genomics demonstrates that
these few driver mutations occur alongside thousands of random
passenger mutationsa natural consequence of cancer's elevated
mutation rate. Some passengers can be deleterious to cancer cells, yet
have been largely ignored in cancer research. In population genetics,
however, the accumulation of mildly deleterious mutations has been shown
to cause population meltdown. Here we develop a stochastic population
model where beneficial drivers engage in a tug-of-war with frequent
mildly deleterious passengers. These passengers present a barrier to
cancer progression that is described by a critical population size,
below which most lesions fail to progress, and a critical mutation rate,
above which cancers meltdown. We find support for the model in cancer
age-incidence and cancer genomics data that also allow us to estimate
the fitness advantage of drivers and fitness costs of passengers. We
identify two regimes of adaptive evolutionary dynamics and use these
regimes to rationalize successes and failures of different treatment
strategies. We find that a tumors load of deleterious passengers can
explain previously paradoxical treatment outcomes and suggest that it
could potentially serve as a biomarker of response to mutagenic
therapies. The collective deleterious effect of passengers is currently
an unexploited therapeutic target. We discuss how their effects might be
exacerbated by both current and future therapies.
From the bioRxiv : http://biorxiv.org/content/early/2014/02/26/003053